Kunyin Qiu

9PUBLICATIONS
8CO-AUTHORS
NeonatologyMedical molecular engineering of nucleic acids and proteinsInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2026
Optimal minimal residual disease threshold in pediatric acute myeloid leukemia: A retrospective cohort study based on the TARGET database.

|Mar 28, 2025
Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531.

Kun-Yin Qiu, Xiong-Yu Liao, Jian-Pei Fang

|Sep 28, 2024
Treatment of pediatric refractory or relapsed Epstein-Barr virus-associated hemophagocytic syndrome with PD-1 inhibitors.

Shu-Yi Guo, Jian Wang, Jian-Pei Fang

|Sep 28, 2023
Real-World Presentation and Prognostic Effect of Allogeneic Blood Transfusion during the Intensive Induction Phase in Pediatric Acute Lymphoblastic Leukemia.

Kunyin Qiu, Xiongyu Liao, Yang Li

|Mar 06, 2023
Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial.

Kun-Yin Qiu, Jia-Yi Wang, Li-Bin Huang

|Nov 24, 2021
CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia.

Xiong-Yu Liao, Jian-Pei Fang, Dun-Hua Zhou

Pageof 2

Frequent Collaborators

1 joint publications

Dun-Hua Zhou

1 joint publications

Lu-Hong Xu

1 joint publications

Jian-Pei Fang

1 joint publications

Jia-Ying Lei